English
-
Analysis: ARV procurement, Russia 2019
ITPC-ru’s 10th year of community-monitoring and analysis in the Russian Federation.
-
Campaign toolkit – our complete guide
Our toolkit will guide you through all the steps to challenge intellectual property barriers, from the life-cycle of a patent,...
-
Access Granted
A budget advocacy toolkit for improving access to quality and affordable medicines through Global Fund grants.
-
Evergreening patents animation
This animation introduces the concept of ‘evergreening’ patents – strategies used by pharmaceutical companies to extend monopolies and keep prices...
-
Minimum costs to manufacture new treatments for COVID-19
‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Researchers from the University of...
-
COVID-19 drugs can be made for $1 a day
Our short film (1m 47 secs) shows how all potential drugs for the treatment of COVID-19 can be made affordably....
-
The problem with patents
This joint policy brief outlines how patents, and their effect on the cost of HIV treatment, threatens to undermine the HIV response in middle-income countries.
-
Access to Hep C treatment among people who inject drugs
A publication produced by Treatment Action Group (TAG) and Médecins du Monde.
-
Patentability criteria
A research synthesis, produced by Knowledge Portalia.
-
Global Survey on Access to and Quality of HIV Treatment and Care
The 2019 survey focused on barriers to quality HIV care and treatment across 14 low- and middle-income countries covering seven...